Profiling of immune-related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation

European Journal of Haematology

Volumn 88, Issue 1, 2012, Pages 31-38

  Takahashi, Naoyuki ^a,b   Nakaoka, Takashi ^c   Yamashita, Naohide ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b MITSUBISHI MATERIALS CORPORATION   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Adult blood; Cord blood; Expression profiling; MicroRNA; Monocytes; T cells

Indexed keywords

GAMMA INTERFERON; LET 7C PROTEIN; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 132; MICRORNA 146B 5P; MICRORNA 155; MICRORNA 15B; MICRORNA 164A; MICRORNA 181A; MICRORNA 181C; MICRORNA 18A; MICRORNA 21; MICRORNA 22; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 34C; MICRORNA 363; MICRORNA 424; RNA; UNCLASSIFIED DRUG;

ADULT; ADULT PERIPHERAL BLOOD CELL; ARTICLE; BLOOD CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; IMMUNITY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ACUTE DISEASE; ADULT; ANTIGENS, CD; ANTIVIRAL AGENTS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MALE; MICRORNAS; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 83655161362     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01707.x     Document Type: Article

References (28)

1. Brown JA, Boussiotis VA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008;127:286-97.
2. Szabolcs P, Park KD, Reese M, Marti L, Broadwater G, Kurtzberg J. Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 2003;31:708-14.
3. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen-presenting cell function in human neonates. Clin Immunol 2006;121:251-9.
4. Wang Y, Lee CG. MicroRNA and cancer - focus on apoptosis. J Cell Mol Med 2009;13:12-23.
5. Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008;18:131-40.
6. + T cells. Blood 2009;113:6648-57.
7. Merkerova M, Vasikova A, Belickova M, Bruchova H. MicroRNA expression profiles in umbilical cord blood cell lineages. Stem Cells Dev 2010;19:17-26.
8. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007;104:1604-9.
9. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007;12:414-8.
10. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-43.
11. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
12. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F, Croce CM, Brunetti E, Grignani F, Peschle C. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007;9:775-87.
13. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008;22:894-907.
14. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
15. Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 2008;10:788-801.
16. Takahashi N, Sato N, Takahashi S, Tojo A. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation. Exp Hematol 2008;36:1760-70.
17. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20.
18. + T cells via TLR4 complex. Eur J Immunol 2009;39:1564-72.
19. Koch A, Knobloch J, Dammhayn C, Raidl M, Ruppert A, Hag H, Rottlaender D, Müller K, Erdmann E. Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics. Clin Immunol 2007;125:194-204.
20. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, Jain MK. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem 2005;280:38247-58.
21. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998;281:1001-5.
22. Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 2009;30:383-91.
23. Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004;5:1052-60.
24. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007;129:147-61.
25. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179:5082-9.
26. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103:12481-6.
27. Nahid MA, Pauley KM, Satoh M, Chan EK. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 2009;284:34590-9.
28. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F, Boshoff C. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 2010;12:513-9.